MedTrace Logo

Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With Prediabetes

NCT07762768 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-08-13

No results posted yet for this study

Summary

This is a randomized, controlled, two-phase crossover study will be conducted in adults aged 18-60 years with prediabetes to compare the effects of a CSIR-developed high-protein, low-glycaemic index rice with conventional rice. Phase I will evaluate acute postprandial glucose, insulin, C-peptide, GLP-1, and hunger/satiety responses, while Phase II will assess 72-hour continuous glucose monitoring (CGM) outcomes, including mean glucose and glycaemic variability. Eligible participants will be randomly assigned to receive both rice types in a crossover manner, with each participant serving as their own control. Individuals with diabetes, major systemic illnesses, abnormal liver or renal function, pregnancy, or glucose-lowering medication use will be excluded.

Conditions

Interventions

DIETARY_SUPPLEMENT

Intervention Group

High-Protein, Low-Glycaemic Index Rice

Sponsors & Collaborators

  • National Diabetes, Obesity and Cholesterol Foundation (N-DOC)

    collaborator UNKNOWN

  • CSIR National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram

    collaborator UNKNOWN

  • Diabetes Foundation, India

    lead OTHER

Principal Investigators

  • Anoop Misra, M.D. · National Diabetes, Obesity and Cholesterol Foundation (N-DOC)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-02-15
Completion
2027-02-28

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07762768 on ClinicalTrials.gov